NICE Update: Systemic anti-cancer therapy for advanced non-small-cell lung cancer, treatment options
NICE has published an update to the NICE Systemic anti-cancer therapy for advanced non‑small‑cell lung cancer: treatment options summary (PDF).
New NICE Result: Lorlatinib
BTOG is disappointed that lorlatinib has not been recommended, within its marketing authorisation, for treating anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in adults who have not had an ALK inhibitor (1st line, CROWN indication). This recommendation … Read More
New NICE Approval: Selpercatinib
BTOG wishes to inform members of a new NICE approval that has been published today.NICE has appraised selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancer and BTOG is delighted it has been given a positive recommendation for the following: … Read More
New NICE Approval: Dabrafenib-Trametinib
BTOG wishes to inform members of a new NICE approval that has been published today. NICE has now reappraised dabrafenib-trametinib for BRAF V600E mutant advanced NSCLC and given a positive recommendation for the submitted indication: 1st line BRAF V600E advanced … Read More
NICE publishes quality standard on tobacco
NICE has published the Tobacco: Treating Dependence quality standard (QS207). BTOG endorses this hugely helpful quality standard which covers support and treatment to stop smoking and stop using smokeless tobacco, and harm-reduction approaches for people who are not ready to … Read More
NICE tobacco guidelines published
The final NICE guideline on Tobacco: preventing uptake, promoting quitting and treating dependence has been published on the NICE website. You can also find the supporting evidence, tools and resources as well as all the stakeholder comments that were received … Read More
NICE Quality Standard (QS17) on lung cancer in adults – Published 26 March 2012 – Last updated 13 December 2019
NICE quality standards describe high-priority areas for quality improvement in a defined care or service area. Each standard consists of a prioritised set of specific, concise and measurable statements. NICE quality standards draw on existing NICE or NICE-accredited guidance that … Read More
NICE Impact on Lung Cancer Report – November 2019
The National Institute for Health and Care Excellence’s (NICE) latest impact report on lung cancer was published in November 2019. The impact report brings together NICE recommendations and real-world data to highlight how implementing NICE guidance is making a difference … Read More